UFPT UFP Technologies Inc SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

UFP Technologies (UFPT) Stock: Buy, Sell, or Hold?

$314.04
-4.82 (-1.51%) ▼
5d: +12.03% 30d: +6.16% 90d: -2.61%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (25%)
Quality Score
56/100
Position
EXTENDED
30-Day Fair Range
$285.37 – $306.98
Position: EXTENDED
Forward P/E & Valuation
26.5x STRETCHED
vs 21.7x historical avg
Wall Street Target
$357.50
+13.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$277.81 / $342.11
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: UFPT trades at premium valuation expecting 6.7% growth. Hold existing positions but don't chase. Wait for better entry.

Get Alerted When UFPT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$376.18
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$233.58
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: UFPT is currently trading at $314.04, which is considered extended relative to its 30-day fair value range of $285.37 to $306.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.4) compared to its historical average (21.7). At these levels, the market is pricing in 6.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, UFPT is in a uptrend. Immediate support is located at $277.81, while resistance sits at $342.11.

Market Sentiment: UFPT scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $357.50 (+13.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $285.37 - $306.98
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 25.2%

Trading Range & Key Levels

30-Day Trading Range $285.37 - $306.98
Current vs Trading Range EXTENDED
Support Level $277.81
Resistance Level $342.11
Current Trend Uptrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (38/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($357.50)
  • NEUTRAL: Trading at premium valuation - market expects 6.7% growth which is achievable

Fundamental Context

Forward P/E (Next Year Est.) 26.45
Wall Street Target $357.50 (+13.8%)
Revenue Growth (YoY) 11.6%
Earnings Growth (YoY) 25.1%
Profit Margin 11.8%
Valuation Premium vs History +6.7% premium
PE vs Historical 26.5 vs 21.7 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.7% (market-implied from PE analysis)
1-Year Target $335.08 (+7%)
2-Year Target $357.53 (+14%)
3-Year Target $381.49 (+22%)
3-Yr Target (if PE normalizes) (PE: 26→22) PE COMPRESSION $312.96 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 26.5, Growth: 11.8%) $438.77 (+40%)
Base: (SPY PE: 19.9, Growth: 11.8%) $329.44 (+5%)
Bear: (PE: 16.9, Growth: 11.8%) $280.02 (-11%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 32.57 | Current EPS (TTM): $9.79
Bull Case $425.36 (+35%)
Analyst growth 21.3%, PE expands to 35.8
Base Case $386.69 (+23%)
Market implied 21.3%, PE stable at 32.6
Bear Case $216.83 (-31%)
Severe decline -20.0%, PE contracts to 27.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share UFPT Analysis

Share this live UFPT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (UFPT)

Bearish 1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on UFPT are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:43 AM ET
Data refreshes hourly during market hours. Next update: 6:43 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for UFPT.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 47 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$112 42 HOLD
BSX
Boston Scientific Corp
BUY
31 analysts
$50 53 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 37 SELL
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 31 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive UFPT Research Pages
UFPT Technical Chart UFPT Price Prediction UFPT Intrinsic Value DCF UFPT Earnings Date UFPT Investment Advisor UFPT Fair Price Analyzer UFPT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals